Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
27 October 2016
Header
Header image
News

News

EFPIA Welcomes Second EUIPO/EPO Report As Clear Evidence of IPR-Intensive Industries' Significant Value to the EU Economy
25 October 2016

EFPIA welcomes the publication of the European Union Intellectual Property Office (EUIPO) and European Patent Office (EPO) joint report on the value of intellectual property [...] Read more

Events calendar

Events Calendar

EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe
From 09/11/2016 to 10/11/2016 (Brussels)

The event will bring together patient organisation representatives, healthcare professionals and industry leaders from across Europe to encourage dialogue and share best practice.

This year we will be focusing on the challenges and opportunities in developing a more outcomes-driven, sustainable approach to healthcare in Europe as well as optimal patient engagement throughout the lifecycle of a medicine.

Read more

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference
From 15/11/2016 to 16/11/2016 (London, UK)

The FT Global Pharmaceutical and Biotechnology Conference, now in its 34th successful year, brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry and the business models and transformation strategies that will be needed to survive and thrive in an industry in flux.

Transformational shifts in healthcare markets herald challenges as well as opportunities ahead for the global life science industry. Considerations around value and outcomes of drug and other medical interventions are becoming a part of the fabric of the industry as health technology assessment and integrated care models gain traction in a growing number of markets.

For more information, click here.

Read more

Events Calendar

The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment - European Meeting of the International Society for Medical Publication Professionals (ISMPP)
From 17/01/2017 to 18/01/2017 (London, UK)

The 2017 European Meeting of the International Society for Medical Publication Professionals (ISMPP) will be held 17-18 January, in London, UK, and it will focus on “The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment”. Two full days of educational programming will provide networking opportunities, interactive roundtables, plenary sessions, member research, and exhibitors displaying cutting edge products and services.

Read more

What we are reading

What we are reading

EU-Canada trade deal: Belgians break Ceta deadlock
27 October 2016 (BBC)

Belgian political leaders have reached a consensus in support of the Ceta trade deal between the EU and Canada, Prime Minister Charles Michel has said.

Read more

What we are reading

Personalised Medicine Conference 2016 Report
27 October 2016 (EUROPEAN COMMISSION - Directorate-General for Research and Innovation)

The goal of personalised medicine is to put the citizen at the centre of healthcare. It is a new paradigm in medicine based on the smart use of technology, coupled with greater participation by patients in the management of their own health, to help prevent disease and promote healthy living. When diseases can be prevented and not only treated, the cost of healthcare will come down, creating a virtuous circle for health policy. The Personalised Medicine conference addressed the broader policy perspective and challenges by showcasing integrated healthcare models in Member States and business approaches that involve patients more directly in their healthcare. The meeting was organised around five challenges. 

Read more

What we are reading

IMI Newsletter
27 October 2016 (IMI)

The October IMI newsletter is out, with updates on events, Calls, and great stories from the projects.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail